Intratumoral T2 hyperintensity was more frequently observed in HER2-low breast cancer than in HER2-zero and HER2-overexpressing cancers (p = 0.009 and p = 0.008, respectively). This evidence concerns the gene ERBB2 and breast carcinoma.